Archrock (AROC) | Q3 2007 | 472,010.87% |
Oxley Bridge Acquisition Limited Class A Ordinary Shares (OBA) | Q3 2007 | 1,808.28% |
Travere Therapeutics (TVTX) | Q3 2007 | 600% |
ACCESS Newswire (ACCS) | Q3 2007 | 458.93% |
QXO (QXO) | Q3 2007 | 333.33% |
Biocardia (BCDA) | Q3 2007 | 300% |
Viewbix Inc Common Stock (VBIX) | Q3 2007 | 177.78% |
Smart Powerr (CREG) | Q3 2007 | 164% |
Alnylam Pharmaceuticals (ALNY) | Q3 2007 | 114.32% |
Sanara Medtech (SMTI) | Q3 2007 | 113.33% |
Riot Platforms (RIOT) | Q3 2007 | 109.78% |
Capricor Therapeutics (CAPR) | Q3 2007 | 109.76% |
ALT5 Sigma (ALTS) | Q3 2007 | 103.1% |
AI Financial (AIFC) | Q3 2007 | 103.1% |
Lexaria Bioscience (LEXX) | Q3 2007 | 102.53% |
Repro Med Systems (KRMD) | Q3 2007 | 100% |
CBAK Energy Technology (CBAT) | Q3 2007 | 95.97% |
Biomerica (BMRA) | Q3 2007 | 92.5% |
Arts-Way Manufacturing (ARTW) | Q3 2007 | 90.52% |
Taoping (TAOP) | Q3 2007 | 85.57% |
Corcept Therapeutics (CORT) | Q3 2007 | 78.83% |
Galectin Therapeutics (GALT) | Q3 2007 | 76.32% |
Wynn Resorts (WYNN) | Q3 2007 | 74.58% |
Las Vegas Sands (LVS) | Q3 2007 | 71.45% |
China Natural Resources (CHNR) | Q3 2007 | 69% |
